Luca Afferi, Martin Spahn, Stefanie Hayoz, Räto T Strebel, Sacha I Rothschild, Helge Seifert, Berna C Özdemir, Bernhard Kiss, Philipp Maletzki, Daniel Engeler, Gregory Wirth, Boris Hadaschik, Ilaria Lucca, Hubert John, Andreas Sauer, Michael Müntener, Lukas Bubendorf, Martina Schneider, Jana Musilova, Ulf Petrausch, Richard Cathomas
OBJECTIVE: To report on the surgical safety and quality of pelvic lymph node dissection (PLND) in patients treated with radical cystectomy (RC) and PLND for muscle-invasive bladder cancer (MIBC) after neoadjuvant chemo-immunotherapy. PATIENTS AND METHODS: The Swiss Group for Clinical Cancer Research (SAKK) 06/17 was an open-label single-arm phase II trial including 61 cisplatin-fit patients with clinical stage (c)T2-T4a cN0-1 operable urothelial MIBC or upper urinary tract cancer...
March 8, 2024: BJU International